Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Kreling

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Health Care Financing Review|January 4, 1990
Assessing potential prescription reimbursement changes: estimated acquisition costs in WisconsinD H Kreling
Health Affairs (Project Hope)|January 31, 2002
Imperfect dataD H Kreling
Pharmacoeconomics|November 4, 1993
The cost effectiveness of drug utilisation review in an outpatient settingD H Kreling, D A Mott
Inquiry : a Journal of Medical Care Organization, Provision and Financing|May 23, 1998
The association of insurance type with costs of dispensed drugsD A Mott, D H Kreling
American Journal of Hospital Pharmacy|April 1, 1991
Potential economic impact of changes in Medicaid drug program purchasingD H Kreling, D A Mott
Journal of Pharmaceutical Marketing & Management|February 4, 1988
Selecting health insurance: the importance of prescription drug coverage and pharmacy factors in consumer decision makingD H Kreling, J B Wiederholt
American Journal of Hospital Pharmacy|February 1, 1992
Drug product management in health maintenance organizationsD H Kreling, R E Mucha
Medical Care|July 1, 1986
Estimating pharmacy level prescription drug acquisition costs for third-party reimbursementD H Kreling, K W Kirk
Health Economics|November 1, 1994
An internal rate of return approach to investigate pharmacist supply in the United StatesD A Mott, D H Kreling
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|June 11, 1999
Effect of a change in third party reimbursement rate on prescription gross marginJ M Ganther, D H Kreling
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Health Care Financing Review|January 4, 1990
Assessing potential prescription reimbursement changes: estimated acquisition costs in WisconsinD H Kreling
Health Affairs (Project Hope)|January 31, 2002
Imperfect dataD H Kreling
Pharmacoeconomics|November 4, 1993
The cost effectiveness of drug utilisation review in an outpatient settingD H Kreling, D A Mott
Inquiry : a Journal of Medical Care Organization, Provision and Financing|May 23, 1998
The association of insurance type with costs of dispensed drugsD A Mott, D H Kreling
American Journal of Hospital Pharmacy|April 1, 1991
Potential economic impact of changes in Medicaid drug program purchasingD H Kreling, D A Mott
Journal of Pharmaceutical Marketing & Management|February 4, 1988
Selecting health insurance: the importance of prescription drug coverage and pharmacy factors in consumer decision makingD H Kreling, J B Wiederholt
American Journal of Hospital Pharmacy|February 1, 1992
Drug product management in health maintenance organizationsD H Kreling, R E Mucha
Medical Care|July 1, 1986
Estimating pharmacy level prescription drug acquisition costs for third-party reimbursementD H Kreling, K W Kirk
Health Economics|November 1, 1994
An internal rate of return approach to investigate pharmacist supply in the United StatesD A Mott, D H Kreling
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|June 11, 1999
Effect of a change in third party reimbursement rate on prescription gross marginJ M Ganther, D H Kreling
Pageof 2